ATHIRA PHARMA INC's ticker is ATHA and the CUSIP is 04746L104. A total of 114 filers reported holding ATHIRA PHARMA INC in Q1 2022. The put-call ratio across all filers is 0.36 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $572,482 | -33.9% | 283,327 | -3.5% | 0.00% | – |
| Q2 2023 | $865,919 | -45.2% | 293,532 | -53.6% | 0.00% | – |
| Q1 2023 | $1,580,870 | +82668.1% | 632,348 | +4.9% | 0.00% | – |
| Q4 2022 | $1,910 | -99.9% | 602,553 | +1.7% | 0.00% | – |
| Q3 2022 | $1,760,000 | +0.4% | 592,704 | +3.1% | 0.00% | – |
| Q2 2022 | $1,753,000 | -76.9% | 574,941 | +2.1% | 0.00% | -100.0% |
| Q1 2022 | $7,600,000 | +4.3% | 563,037 | +0.6% | 0.00% | 0.0% |
| Q4 2021 | $7,290,000 | +101.5% | 559,500 | +45.0% | 0.00% | – |
| Q3 2021 | $3,618,000 | -13.9% | 385,748 | -6.0% | 0.00% | -100.0% |
| Q2 2021 | $4,201,000 | -8.1% | 410,290 | +65.1% | 0.00% | 0.0% |
| Q1 2021 | $4,573,000 | -39.3% | 248,561 | +13.1% | 0.00% | 0.0% |
| Q4 2020 | $7,529,000 | – | 219,853 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 1,691,623 | $57,938,000 | 8.52% |
| ACUTA CAPITAL PARTNERS, LLC | 393,000 | $13,460,000 | 3.66% |
| Logos Global Management LP | 947,873 | $32,465,000 | 2.78% |
| RTW INVESTMENTS, LP | 2,685,779 | $88,899,000 | 1.49% |
| Avidity Partners Management LP | 1,043,873 | $35,753,000 | 1.16% |
| Perceptive Advisors | 3,114,805 | $106,682,000 | 1.14% |
| Sofinnova Investments, Inc. | 509,168 | $17,439,000 | 1.04% |
| HighVista Strategies LLC | 32,062 | $1,098,000 | 0.70% |
| Rock Springs Capital Management LP | 860,902 | $29,486,000 | 0.62% |
| PFM Health Sciences, LP | 470,227 | $16,105,000 | 0.57% |